b 27

Influenza A NP (383-391) (HLA-B27) 是从破伤风毒素中提取的多肽序列.该序列作为CD4+ T 辅助细胞表位具有高免疫原性,有助于增强CD8+ 细胞毒性T淋巴细胞 (CTL) 的反应.此外,Influenza A NP (383-391) (HLA-B27) 也用于乳腺癌的研究工作中.

MAO-B-IN-27（Compound 12c）是一种针对单胺氧化酶B（MAO-B）的有效且选择性的抑制剂，展现出对hMAO-B的显著抑制活性，具有8.9 nM的IC50值，用于帕金森病（PD）研究。

Cbl-b-IN-27，作为B淋巴瘤原癌基因b (Cbl-b)的抑制剂，展现出IC50值为7 nM的抑制效果。该化合物主要用于探究效应T细胞、T细胞、自然杀伤(NK)细胞以及B细胞活化调节的研究领域。

HBcAg (core antigen) is a hepatitis B viral protein. It is an indicator of active viral replication; this means the person infected with Hepatitis B can likely transmit the virus on to another person.

Calpastatin (184-210), an acetylated synthetic peptide derived from human calpastatin, effectively inhibits the calcium-dependent cysteine proteases, calpain I (µ-calpain) and calpain II (m-calpain), which require micromolar and millimolar calcium concentrations, respectively. Unlike its action on calpains, this 27 amino acid peptide does not inhibit papain (a cysteine protease) or trypsin (a serine protease). Encoded by exon 1B of Ac-calpastatin (184-210), it aligns with a section of inhibitory domain 1, showcasing its specificity and inhibitory function towards calpain enzymes.

HSD17B13-IN-27 (compound 30) 作为hydroxysteroid 17?-dehydrogenase 13 (HSD17B13) 的高效抑制剂，其针对雌二醇和白三烯 B3 的IC50值分别为小于 0.1 μM 和小于 1 μM。该化合物在非酒精性脂肪肝疾病 (NAFLD) 及其子类非酒精性脂肪性肝炎 (NASH) 的研究中显示出显著的应用潜力。

Anti-MouseIL-27p28 Antibody (MM27.7B1) 是来源于小鼠的 IgG2a, κ 抗体抑制剂，用于阻止小鼠IL-27p28。

SB 272183 is a highly potent dual 5-HT1A and 5-HT1B antagonists as potential antidepressant drug.

SB 271046 hydrochloride (SB 271046A) 是高效、选择性和具有口服活性的5-HT6受体拮抗剂，对大鼠、猪和人的pKi 分别为 9.02、8.55 和 8.81。它增加额叶皮层中的细胞外天冬氨酸和谷氨酸并表现出抗惊厥活性，EC50为 0.16 μM。它对 5-HT6 受体、结合位点和离子通道的选择性超过 200 倍。

SB-277011 (SB-277011A) 是多巴胺 D3 受体的特异性拮抗剂，对 D3 受体、D2 受体、5-HT1D 和 5-HT1B 的 pKi 值分别为 8.0、6.0、5.0 和 <5.2。

ARB-272572 是一种强效的程序性细胞死亡配体 1 （PD-L1）信号传导抑制剂，可诱导 PD-L1 同型二聚体相互作用，可在人原代细胞中产生免疫刺激活性。

SB-277011 hydrochloride (SB-277011A hydrochloride) 是一种可口服且具有选择性、强效性和脑渗透性的多巴胺 D3 受体(D3R) 拮抗剂，在大鼠中诱导的射精延迟。SB-277011 hydrochloride 可用于研究神经系统疾病。

SB273005 是一种具有口服活性和高效性非肽整合素αvβ3 拮抗剂，抑制 αvβ3 和 αvβ5，可减少怀孕小鼠中 Th2 细胞和细胞因子 IL-10 的产生。

ARB-272572 hydrochloride 是一种小分子 PD-L1 抑制剂，对PD-1 PD-L1 HTRF的 IC50 值为 400 pM。ARB-272572 hydrochloride 通过诱导 PD-L1 蛋白同源相互作用来抑制 PD-1 PD-L1 细胞信号传导。

SB-277011 dihydrochloride is a potent, selective, orally bioavailable and brain penetrate antagonist of dopamine D3 receptor(pKis of 8.0, 6.0, <5.2 and 5.9 for D3, D2, 5-HT1B, and 5-HT1D receptors, respectively).

AZD1386 is a TRPV1 antagonist. AZD1386 acts as a competitive antagonist at the channel's capsaicin binding site.

PMMB276 是一种有效的 β-微管蛋白同种型 III (Tubb3) 聚合及细胞凋亡 (apoptosis) 抑制剂，并在癌症研究中具有重要作用。

BTK inhibitor 1 (Compound 27）是一种BTK 抑制剂（IC50：0.11nM），对hWB 中的B 细胞活化具有抑制作用，IC50为2nM。

Tobramycin Sulfate (Dartobcin) 是一种具有抗菌活性的纳米抗生素，可用于研究儿童细菌性肺炎。

β-Endorphin (1-27) (human) acetate 存在于大脑垂体和下丘脑中，具有镇痛活性。 β-Endorphin (1-27) (human) acetate 是一种阿片受体激动剂，对 μ-阿片受体和 δ-阿片受体具有较好的亲和力。

Rineterkib hydrochloride (compound B) is an orally active RAF and ERK1 2 inhibitor in the treatment of a proliferative disease characterized by activating mutations in the MAPK pathway. The activity is particularly related to the treatment of KRAS-mutant NSCLC, BRAF-mutant NSCLC, KRAS-mutant pancreatic cancer, KRAS-mutant colorectal cancer (CRC) and KRAS-mutant ovarian cancer[1]. ERK-IN-1 (compound B) (50, 75 mg kg, p.o., qd q2d, 27 days) treatment significantly reduces the tumor volume in the Calu-6 human NSCLC subcutaneous tumor xenograft model in mice[1]. [1]. CAPONIGRO, et al. THERAPEUTIC COMBINATIONS COMPRISING A RAF INHIBITOR AND A ERK INHIBITOR. WO2018051306A1.

β-Endorphin (1-27) is an endogenous peptide that binds to μ-, δ-, and κ-opioid receptors (Kis = 5.31, 6.17, and 39.82 nM, respectively, in COS-1 cells expressing rat receptors). It binds to rat and mouse brain membrane preparations (IC50s = 1.1 and 5.7 nM, respectively) and induces chemotaxis of human monocytes in vitro when used at a concentration of 1 nM. Intracerebroventricular administration of β-endorphin (1-27) increases the latency to tail withdrawal in response to thermal stimulation in mice with a median antinociceptive dose (AD50) of 1,500 pmol per animal. It inhibits antinociception induced by β-endorphin in mice in response to thermal stimuli when administered at a dose of 65 pmol per animal. In rats, β-endorphin (1-27) does not affect drug-associated place preference when administered at doses up to 20 μg, i.c.v., but inhibits β-endorphin-induced place preference when administered at a dose of 10 μg per animal.

PHA-680632 是一种极光激酶抑制剂，对极光激酶 A、B 和C 的IC50值分别为 27、135和 120 nM。它对 FGFR1、FLT3、LCK、PLK1、STLK2 和 VEGFR2 3 的 IC50 高 10 到 200 倍。

HBVSeq1 aa:18-27 是乙型肝炎病毒 (HBV) 核心抗原 18-27 肽片段。